Skip to content.
Menu
Team
Team
Our philosophy
Companies
Build
Spotlight
Team
Team
Our philosophy
Companies
Build
Spotlight
Spotligh
t
Featured
Perspectives
Why we invested in OpenTrade
Read: Why we invested in OpenTrade
1 / 10
Read more
Perspectives
Why we invested in Infact
Read: Why we invested in Infact
2 / 10
Read more
Perspectives
Why we invested in trumpet
Read: Why we invested in trumpet
3 / 10
Read more
Perspectives
Why we invested in Instinct
Read: Why we invested in Instinct
4 / 10
Read more
Perspectives
Why we invested in Treefera
Read: Why we invested in Treefera
5 / 10
Read more
Perspectives
Why we invested in Oriole Networks
Read: Why we invested in Oriole Networks
6 / 10
Read more
Perspectives
Why we invested in Gridcog
Read: Why we invested in Gridcog
7 / 10
Read more
Perspectives
Why we invested in OpenDialog
Read: Why we invested in OpenDialog
8 / 10
Read more
Perspectives
Why we invested in kennek?
Read: Why we invested in kennek?
9 / 10
Read more
Perspectives
Why we invested in tem.?
Read: Why we invested in tem.?
10 / 10
Read more
All
Deep dives
Events
Founder stories
News
Perspectives
Web
All
AI / Data
Climate Tech
Deeptech
Digital Risk
Fintech
Healthtech
Life Sciences
UCL Tech Fund
Search for:
Search
News
EpilepsyGTx announces a $10m seed round to treat focal refractory epilepsy
Read the article >
News
AstronauTx closes a £48 million Series A to treat Alzheimer’s disease
Read the article >
News
Tenpoint Therapeutics launches with $70 million Series A
Read the article >
News
What to expect in 2023?
Predictions for 2023
Read the article >
News
Bloomsbury GTX launches with Seed financing of £5m to develop the promise of gene therapy
Bloomsbury GTX raises £5m Seed funding to develop curative gene therapy treatments
Read the article >
